Sodium valproate increases pupillary responsiveness to a cholinergic agonist in responders with mania

Biological Psychiatry

Volumn 46, Issue 3, 1999, Pages 432-436

  Demet, Edward M ^a   Sokolski, Kenneth N ^b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholinergic; Mania; Pupil; Valproate

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; EYE DROPS; LITHIUM; NEUROLEPTIC AGENT; PILOCARPINE; TROPICAMIDE; VALPROATE SEMISODIUM; VALPROIC ACID;

ADULT; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; MANIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUPIL; TOPICAL DRUG ADMINISTRATION;

ADULT; BIPOLAR DISORDER; CHOLINERGIC AGONISTS; HUMANS; MALE; MIDDLE AGED; MUSCARINIC AGONISTS; PILOCARPINE; RECEPTORS, MUSCARINIC; REFLEX, PUPILLARY; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0032811147     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00028-1     Document Type: Article

References (28)

1. Baf M.H., Subhash M.N., Lakshmana K.M., Rao B.S. Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochem Int. 24:1994;67-72.
2. Bech P., Bolwig T.G., Kramp P., Rafaelsen O.J. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatrica Scand. 59:1979;420-430.
3. Chen G., Manji H.K., Hawver D.B., Wright C.B., Potter W.Z. Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. J Neurochem. 63:1994;2361-2364.
4. de la Vega M.T., Nunez A., Arias-Montano J.A. Muscarinic M-1 and M-3 receptors in rat striatum a binding study . Arch Med Res. 28:1997;493-497.
5. Fanciullacci M., Sicuteri R., Alessandri M., Geppetti P. Buspirone, but not sumatriptan, induces miosis in humans relevance for a serotoninergic pupil control . Clin Pharmacol Ther. 57:1995;349-355.
6. Gabelt B.T., Kaufman P.L. Inhibition of aceclidine-stimulated outflow facility, accommodation, and miosis in rhesus monkeys by muscarinic receptor subtype antagonists. Exp Eye Res. 58:1994;623-630.
7. Gritti I., Mainville L., Mancia M., Jones B.E. GABAergic and other noncholinergic basal forebrain neurons, together with cholinergic neurons, project to the mesocortex and isocortex in the rat. J Comp Neurol. 383:1997;163-177.
8. Heller P.H., Perry F., Jewett D.L., Levine J.D. Autonomic components of the human pupillary light reflex. Invest Ophthal Vis Sci. 31:1990;156-162.
9. Janowsky D.S., Risch S.C. Cholinomimetic and anticholinergic drugs used to investigate a cholinergic hypothesis of affective disorder and stress. Drug Dev Res. 4:1984;125-142.
10. Janowsky D.S., el-Yousef M.K., Davis J.M., Sekerke H.J. A cholinergic-adrenergic hypothesis of mania and depression. Lancet. 2:1972;632-635.
11. Jope R.S., Williams M.B. Lithium and brain signal transduction systems. Biochem Pharmacol. 47:1994;429-441.
12. Kaufer D., Friedman A., Seidman S., Soreq H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature. 393:1998;373-377.
13. Kelwala K (1984): Depressed patients exhibit increased miosis to pilocarpine. Abstract no. 112. New Research, Am. Psychiatric Assoc. Meeting, Los Angeles, CA, May 1984.
14. Lenox R.H., McNamara R.K., Watterson J.M., Watson D.G. Myristoylated alanine-rich C kinase substrate (MARCKS) a molecular target for the therapeutic action of mood stabilizers in the brain? J Clin Psychiatry. 57:(suppl 13):1996;23-31.
15. Lenox R.H., McNamara R.K., Parke R.L., Manji H.K. Neurobiology of lithium an update . J Clin Psychiat. 59:(suppl 6):1998;37-47.
16. Loewenfeld I.E. Pupillary changes related to age. Thompson H.S., Daroff R., Frisen L., Glaser J.S., Sanders M.D. Topics in Neuro-Ophthalmology. 1979;124-150 Williams and Wilkins, Baltimore.
17. Maes M., Calabrese J., Jayathilake K., Meltzer H.Y. Effects of subchronic treatment with valproate on L-5HTP-induced cortisol responses in mania evidence for increased central serotonergic neurotransmission . Psychiatry Res. 71:1997;67-76.
18. Mitsikostas D., Sfikakis A., Papadopoulou-Daifoti Z., Varonos D. The effects of valproate in brain monoamines of juvenile rats after stress. Prog Neuro-Psychopharmacol Biol Psychiatry. 17:1993;295-310.
19. Motohashi N. GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. Prog Neuro-Psychopharmacol Biol Psychiatry. 16:1992;571-579.
20. Nurnberger J. Jr, Berrettinni W., Mendelson W., Sack D., Gershon E.S. Measuring cholinergic sensitivity Arecoline effects in bipolar patients . Biol Psychiatry. 25:1989;610-617.
21. Onali P., Olianas M.C. Identification and characterization of muscarinic receptors potentiating the stimulation of adenyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex. J Pharmacol Exp Ther. 286:1998;753-759.
22. Post R.M., Weiss S.R., Chuang D.M. Mechanisms of action of anticonvulsants in affective disorders comparisons with lithium . J Clin Psychopharmacol. 12:(suppl 1):1992;23S-35S.
23. Scinto L.F., Daffner K.R., Dressler D., Ransil B.I., Rentz D., Weintraub S., Mesulam M., Potter H. A potential non-invasive neurobiological test for Alzheimer's disease. Science. 266:1994;1051-1054.
24. Sokolski K.N., DeMet E.M. Increased pupillary sensitivity to pilocarpine in depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 20:1996;253-261.
25. Sokolski K.N., DeMet E.M. Pupillary cholinergic sensitivity to pilocarpine increases in manic lithium responders. Biol Psychiatry. 45:1999;1580-1584.
26. Watson D.G., Watterson J.M., Lenox R.H. Sodium valproate down-regulates the myristoylated alanine rich C kinase substrate (MARCKS) in immortalized hippocampal cells a property of protein kinase C-mediated mood stabilizers . J Pharmacol Exp Ther. 285:1998;307-316.
27. Whitton P.S., Fowler L.J. The effect of valproic acid of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo. Eur J Pharmacol. 200:1991;167-169.
28. Winn B., Whitaker D., Elliott D.B., Phillips N.J. Factors affecting light-adapted pupil size in normal human subjects. Invest Ophthalmol Vis Sci. 35:1994;1132-1137.